Bacterial lipopolysaccharide (LPS) provokes a vigorous, generalized proinflammatory state in the infected host. Genetic regulation of this response has been localized to the Lps locus on mouse chromosome 4, through study of the C3H/HeJ and C57BL/10ScCr inbred strains. Both C3H/HeJ and C57BL/10ScCr mice are homozygous for a mutant Lps allele (Lpsd/d) that confers hyporesponsiveness to LPS challenge, and therefore exhibit natural tolerance to its lethal effects. Genetic and physical mapping of 1,345 backcross progeny segregating this mutant phenotype confined Lps to a 0.9-cM interval spanning 1.7 Mb. Three transcription units were identified within the candidate interval, including Toll-like receptor 4 (Tlr4), part of a protein family with members that have been implicated in LPS-induced cell signaling. C3H/HeJ mice have a point mutation within the coding region of the Tlr4 gene, resulting in a nonconservative substitution of a highly conserved proline by histidine at codon 712, whereas C57BL/ 10ScCr mice exhibit a deletion of Tlr4. Identification of distinct mutations involving the same gene at the Lps locus in two different hyporesponsive inbred mouse strains strongly supports the hypothesis that altered Tlr4 function is responsible for endotoxin tolerance.
Skip Nav Destination
Article navigation
15 February 1999
Article|
February 15 1999
Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)
Salman T. Qureshi,
Salman T. Qureshi
From the *Department of Medicine, ‡Department of Biochemistry, and §Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3G 1A4; the ‖Centre for the Study of Host Resistance, Montreal General Hospital, Montreal, Quebec, Canada H3G 1A4; and ¶Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Search for other works by this author on:
Line Larivière,
Line Larivière
From the *Department of Medicine, ‡Department of Biochemistry, and §Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3G 1A4; the ‖Centre for the Study of Host Resistance, Montreal General Hospital, Montreal, Quebec, Canada H3G 1A4; and ¶Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Search for other works by this author on:
Gary Leveque,
Gary Leveque
From the *Department of Medicine, ‡Department of Biochemistry, and §Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3G 1A4; the ‖Centre for the Study of Host Resistance, Montreal General Hospital, Montreal, Quebec, Canada H3G 1A4; and ¶Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Search for other works by this author on:
Sophie Clermont,
Sophie Clermont
From the *Department of Medicine, ‡Department of Biochemistry, and §Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3G 1A4; the ‖Centre for the Study of Host Resistance, Montreal General Hospital, Montreal, Quebec, Canada H3G 1A4; and ¶Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Search for other works by this author on:
Karen J. Moore,
Karen J. Moore
From the *Department of Medicine, ‡Department of Biochemistry, and §Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3G 1A4; the ‖Centre for the Study of Host Resistance, Montreal General Hospital, Montreal, Quebec, Canada H3G 1A4; and ¶Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Search for other works by this author on:
Philippe Gros,
Philippe Gros
From the *Department of Medicine, ‡Department of Biochemistry, and §Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3G 1A4; the ‖Centre for the Study of Host Resistance, Montreal General Hospital, Montreal, Quebec, Canada H3G 1A4; and ¶Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Search for other works by this author on:
Danielle Malo
Danielle Malo
From the *Department of Medicine, ‡Department of Biochemistry, and §Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3G 1A4; the ‖Centre for the Study of Host Resistance, Montreal General Hospital, Montreal, Quebec, Canada H3G 1A4; and ¶Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Search for other works by this author on:
Salman T. Qureshi
From the *Department of Medicine, ‡Department of Biochemistry, and §Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3G 1A4; the ‖Centre for the Study of Host Resistance, Montreal General Hospital, Montreal, Quebec, Canada H3G 1A4; and ¶Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Line Larivière
From the *Department of Medicine, ‡Department of Biochemistry, and §Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3G 1A4; the ‖Centre for the Study of Host Resistance, Montreal General Hospital, Montreal, Quebec, Canada H3G 1A4; and ¶Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Gary Leveque
From the *Department of Medicine, ‡Department of Biochemistry, and §Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3G 1A4; the ‖Centre for the Study of Host Resistance, Montreal General Hospital, Montreal, Quebec, Canada H3G 1A4; and ¶Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Sophie Clermont
From the *Department of Medicine, ‡Department of Biochemistry, and §Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3G 1A4; the ‖Centre for the Study of Host Resistance, Montreal General Hospital, Montreal, Quebec, Canada H3G 1A4; and ¶Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Karen J. Moore
From the *Department of Medicine, ‡Department of Biochemistry, and §Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3G 1A4; the ‖Centre for the Study of Host Resistance, Montreal General Hospital, Montreal, Quebec, Canada H3G 1A4; and ¶Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Philippe Gros
From the *Department of Medicine, ‡Department of Biochemistry, and §Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3G 1A4; the ‖Centre for the Study of Host Resistance, Montreal General Hospital, Montreal, Quebec, Canada H3G 1A4; and ¶Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Danielle Malo
From the *Department of Medicine, ‡Department of Biochemistry, and §Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3G 1A4; the ‖Centre for the Study of Host Resistance, Montreal General Hospital, Montreal, Quebec, Canada H3G 1A4; and ¶Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Address correspondence to Danielle Malo, Centre for the Study of Host Resistance, Montreal General Hospital, 1650 Cedar Avenue, Rm. L11-144, Montreal, Quebec, H3G 1A4, Canada. Phone: 514-937-6011 ext. 4503; Fax: 514-934-8261; E-mail: [email protected]
Received:
November 25 1998
Revision Received:
December 07 1998
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1999
J Exp Med (1999) 189 (4): 615–625.
Article history
Received:
November 25 1998
Revision Received:
December 07 1998
Connected Content
This article has been corrected
Correction
Citation
Salman T. Qureshi, Line Larivière, Gary Leveque, Sophie Clermont, Karen J. Moore, Philippe Gros, Danielle Malo; Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4) . J Exp Med 15 February 1999; 189 (4): 615–625. doi: https://doi.org/10.1084/jem.189.4.615
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Connected Content
Advertisement